Targeting GRP78 and exploring its regulatory mechanisms offer potential avenues for therapeutic interventions in cancer, diabetes, cardiovascular diseases, and other conditions associated with GRP78 dysregulation. This evidence concerns the gene HSPA5 and diabetes mellitus.